How one foundation keeps funding cancer breakthroughs
An interview with Yung S. Lie, PhD, president and CEO of the Damon Runyon Cancer Research Foundation
The approach to finding and funding “brave and bold” new ideas goes back to 1946.
Betting on basic science is leading to breakthroughs in immune checkpoint inhibitors, CAR-T, targeted therapies, cancer vaccines and more.
The latest research on healthy life and prevention, improving outcomes, reducing side effects and getting the best precision medicine.